Transcutaneous Implantation Methods for Improving the Long-Term Performance of Glucose Sensors in Rats

Translation of sensor design and function in animal models to human use is an ongoing challenge due to tissue anatomical and physiological differences between species, even at presumably analogous implant locations. Nevertheless, preclinical testing of sensors for long-term glucose monitoring in animals is required for evaluating sensor function in order to improve sensor design. Long-term glucose sensor testing in common laboratory animals (e.g., mice and rats) is especially difficult due to their small size, as well as limited site availability for sensor placement without disturbance or removal by the subject. However, improvements in sensor design and implantation methods to improve sensor survival in these animals could accelerate our understanding of the role of tissue reactions to sensor components, as well as allow reliable testing of biomaterials and various drug or growth factor delivery systems to potentially minimize or modulate tissue reactions. In this study, methods to secure a wire-type subcutaneous sensor in rats for a long period of time (ges28 d), utilizing new implantation techniques and devices were evaluated. Anchoring devices were incorporated into the sensor design and appropriate implantation methods were used to: (1) minimize potential membrane damage caused by animal motion; (2) prevent removal of the entire sensor or sensor wires by the animal; and (3) allow exterior access to wires for periodic sensor performance testing. The anchoring devices for securing sensors to the skin internally, which were sequentially investigated and improved (Protocol A to C), included a modified 22 gauge intravenous winged catheter (Protocol A), Silastic tubing (Protocol B) or silk suture loops held in place by Silastic tubing (Protocol C). The results show that after four weeks implantation, 60% (n = 10), 70% (n = 10), and 92% (n = 12) of the implanted devices survived (Protocols A, B, and C, respectively). Functional testing showed that 30% (n = 10), 40% (n = 10), and 58% (n = 12) of the sensors still worked well four weeks after implantation (Protocols A, B, and C, respectively). No infections were visibly evident at the sites of sensor implantation at any time during the testing period for all protocols. Protocol C shows promise as a viable method for future sensor studies because of the anchoring device's small size and because it was nearly impossible for rats to remove or damage the sensors.

[1]  Michael Gerstenberg,et al.  Evaluation of subcutaneously-implanted glucose sensors for continuous glucose measurements in hyperglycemic pigs. , 2006, In vivo.

[2]  Y. Yamasaki,et al.  Telemetry Glucose Monitoring Device With Needle-Type Glucose Sensor: A Useful Tool for Blood Glucose Monitoring in Diabetic Individuals , 1986, Diabetes Care.

[3]  Lynda K Fisher,et al.  Future Developments in Insulin Pump Therapy , 2006, The Diabetes educator.

[4]  S. Garg,et al.  Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. , 2004, Diabetes care.

[5]  Manjot Kaur,et al.  Continuous glucose monitoring in normal mice and mice with prediabetes and diabetes. , 2006, Diabetes technology & therapeutics.

[6]  M. Shults,et al.  Evaluation of a Subcutaneous Glucose Sensor out to 3 Months in a Dog Model , 1994, Diabetes Care.

[7]  M Gerritsen,et al.  [Subcutaneously implantable glucose sensors in patients with diabetes mellitus; still many problems]. , 2002, Nederlands tijdschrift voor geneeskunde.

[8]  E. Renard Implantable glucose sensors for diabetes monitoring , 2004, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[9]  M. Shults,et al.  A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. , 2000, Diabetes care.

[10]  John Pickup,et al.  In vivo glucose sensing for diabetes management: progress towards non-invasive monitoring , 1999, BMJ.

[11]  Francis Moussy,et al.  A long-term flexible minimally-invasive implantable glucose biosensor based on an epoxy-enhanced polyurethane membrane. , 2006, Biosensors & bioelectronics.

[12]  Francis Moussy,et al.  Strategies for testing long-term transcutaneous amperometric glucose sensors. , 2005, Diabetes technology & therapeutics.

[13]  W Kenneth Ward,et al.  An implantable subcutaneous glucose sensor array in ketosis-prone rats: closed loop glycemic control. , 2005, Artificial organs.

[14]  L. Heinemann,et al.  Sensors for glucose monitoring: technical and clinical aspects , 2001, Diabetes/metabolism research and reviews.

[15]  U. Klueh,et al.  Murine model of implantable glucose sensors: a novel model for glucose sensor development. , 2005, Diabetes technology & therapeutics.

[16]  Bazhang Yu,et al.  Lifetime Improvement of Glucose Biosensor by Epoxy-Enhanced PVC Membrane , 2005 .

[17]  Richard D. Beach,et al.  Subminiature implantable potentiostat and modified commercial telemetry device for remote glucose monitoring , 1999, IEEE Trans. Instrum. Meas..

[18]  Kevin Barraclough,et al.  I and i , 2001, BMJ : British Medical Journal.